Mauna Kea Technologies SAS
Research Mauna Kea Technologies SAS (ALMKT) on Bullrun: market cap EUR 30.39M, P/E 1.6. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALMKT
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 30.39M
- P/E1.6
- Financial periodFY2025
- RevenueEUR 8.22M
- Revenue growth7.4%
- Net incomeEUR 10.77M
- Free cash flow-EUR 3.89M
- Gross margin75.3%
Valuation Snapshot
latest market cap is EUR 30.39M; P/E is 1.6.
Peer valuation comparison
Latest P/E is 1.64x versus a Healthcare sector median of 24.46x (93.3% below).
Latest P/E is 1.64x versus a France median of 15.25x (89.2% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 8.22M | EUR 10.77M | -EUR 3.89M | 75.3% | 0.06 | EUR 4.97M | EUR 12.08M | -EUR 4.82M |
| FY2024 | EUR 7.66M | -EUR 10.40M | -EUR 6.54M | 84.1% | -0.16 | EUR 1.92M | EUR 31.93M | -EUR 24.39M |
| FY2023 | EUR 10.48M | -EUR 3.73M | -EUR 1.14M | 79.8% | -0.08 | EUR 7.87M | EUR 29.77M | -EUR 17.28M |
| FY2022 | EUR 7.48M | -EUR 11.18M | -EUR 8.97M | 73.2% | -0.25 | EUR 3.14M | EUR 29.20M | -EUR 19.92M |
| FY2021 | EUR 7.70M | -EUR 13.45M | -EUR 11.37M | 74.2% | n/a | EUR 11.87M | EUR 28.70M | -EUR 10.33M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 30.39M | 1.6 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Mauna Kea Technologies SAS
Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Mauna Kea Technologies SAS's market cap?
Mauna Kea Technologies SAS's market capitalization is EUR 30.39M.
What is Mauna Kea Technologies SAS's P/E ratio?
Mauna Kea Technologies SAS's price-to-earnings (P/E) ratio is 1.6.
What does Mauna Kea Technologies SAS do?
Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate reactions as they occur, classify areas of uncertainty, guide surgical interventions, and help diagnose and treat patients. The company was incorporated in 2000 and is headquartered in Paris, France.